{"title":"JBT核心管理特刊。","authors":"S. Mische","doi":"10.7171/jbt.16-2701-005","DOIUrl":null,"url":null,"abstract":"Progress in biomedical research is largely driven by improvements, innovations, and breakthroughs in technology, an increasingly complex collaboration among basic, preclinical, and clinical science. Unfortunately, this increasing sophistication correlates with both growing research costs and a shrinking federal research budget. Taken together, it makes a strong argument for investing in core facilities. Cores are not new, having been a part of the research landscape for decades. Cores leverage expertise and state-of-the-art technology in centralized facilities and support institutional research in a cost-effective and efficient manner. There is a growing recognition that centralized administration of cores ensures best practices for institutional investment, financial and resource management, and core scientist professional and career development. Centralization maximizes institutional research capabilities by providing state-of-the-art instrumentation and multidisciplinary expertise for the entire research community, establishing a culture of collaboration integrated and aligned with institutional strategic goals and success in a highly competitive playground. However, to be successful, cores requires funding agencies and partners who identify opportunities and provide financial support, scientists who embrace team science, core scientists who personify the ethos of collaborative sharing, and committed institutions and policies that make it happen.","PeriodicalId":94326,"journal":{"name":"Journal of biomolecular techniques : JBT","volume":"5 1","pages":"1"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"JBT Special Issue on Core Management.\",\"authors\":\"S. Mische\",\"doi\":\"10.7171/jbt.16-2701-005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Progress in biomedical research is largely driven by improvements, innovations, and breakthroughs in technology, an increasingly complex collaboration among basic, preclinical, and clinical science. Unfortunately, this increasing sophistication correlates with both growing research costs and a shrinking federal research budget. Taken together, it makes a strong argument for investing in core facilities. Cores are not new, having been a part of the research landscape for decades. Cores leverage expertise and state-of-the-art technology in centralized facilities and support institutional research in a cost-effective and efficient manner. There is a growing recognition that centralized administration of cores ensures best practices for institutional investment, financial and resource management, and core scientist professional and career development. Centralization maximizes institutional research capabilities by providing state-of-the-art instrumentation and multidisciplinary expertise for the entire research community, establishing a culture of collaboration integrated and aligned with institutional strategic goals and success in a highly competitive playground. However, to be successful, cores requires funding agencies and partners who identify opportunities and provide financial support, scientists who embrace team science, core scientists who personify the ethos of collaborative sharing, and committed institutions and policies that make it happen.\",\"PeriodicalId\":94326,\"journal\":{\"name\":\"Journal of biomolecular techniques : JBT\",\"volume\":\"5 1\",\"pages\":\"1\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of biomolecular techniques : JBT\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7171/jbt.16-2701-005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomolecular techniques : JBT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7171/jbt.16-2701-005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Progress in biomedical research is largely driven by improvements, innovations, and breakthroughs in technology, an increasingly complex collaboration among basic, preclinical, and clinical science. Unfortunately, this increasing sophistication correlates with both growing research costs and a shrinking federal research budget. Taken together, it makes a strong argument for investing in core facilities. Cores are not new, having been a part of the research landscape for decades. Cores leverage expertise and state-of-the-art technology in centralized facilities and support institutional research in a cost-effective and efficient manner. There is a growing recognition that centralized administration of cores ensures best practices for institutional investment, financial and resource management, and core scientist professional and career development. Centralization maximizes institutional research capabilities by providing state-of-the-art instrumentation and multidisciplinary expertise for the entire research community, establishing a culture of collaboration integrated and aligned with institutional strategic goals and success in a highly competitive playground. However, to be successful, cores requires funding agencies and partners who identify opportunities and provide financial support, scientists who embrace team science, core scientists who personify the ethos of collaborative sharing, and committed institutions and policies that make it happen.